| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | CEO &President | CEO and President +1 more
2 companies
Gottesdiener Keith Michael is a See Remarks at PRME, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 15 sales. Those positions are worth an estimated $3.4M at current prices.
Gottesdiener Keith Michael's largest disclosed position is in RYTM as CEO &President, worth about $3.4M. The recent filings there lean toward selling, a net 82,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO &President | Sell | 10,290 | $30.09 | $309,647.27 | -2.0% | |
| Mar 14, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO &President | Sell | 9,288 | $30.06 | $279,182.22 | -1.8% | |
| Feb 27, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO and President | Sell | 2,449 | $30.04 | $73,570.69 | -0.5% | |
| Feb 19, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO and President | Sell | 12,920 | $30.02 | $387,885.94 | -2.4% | |
| Feb 13, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO and President | Sell | 3,934 | $30.00 | $118,020.00 | -0.7% | |
| Jan 23, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO and President | Sell | 15,779 | $30.05 | $474,175.75 | -2.8% | |
| Jan 18, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO &President | Sell | 10,115 | $30.01 | $303,551.15 | -1.8% | |
| Jan 16, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | CEO &President | Sell | 662 | $30.00 | $19,860.00 | -0.1% | |
| Dec 3, 2018 | RYTM Rhythm Pharmaceuticals, Inc. | CEO and President | Sell | 563 | $30.00 | $16,890.00 | - | |
| Nov 2, 2018 | RYTM Rhythm Pharmaceuticals, Inc. | CEO and President | Sell | 16,500 | $30.08 | $496,320.00 | -2.8% |